Table 2 Significant association between RAPGEF4 SNPs and cognitive decline

From: Anxiety and depression with neurogenesis defects in exchange protein directly activated by cAMP 2-deficient mice are ameliorated by a selective serotonin reuptake inhibitor, Prozac

RAPGEF4 SNP

Subjects

Genotype

P-value

rs3769219

 

TT

TC

CC

 
 

CDR 1

0 (0%)

12 (9.4%)

115 (90.6%)

**0.003

 

CDR 0.5

0 (0%)

25 (22.5%)

86 (77.5%)

 
 

CDR 0

0 (0%)

45 (24.5%)

139 (75.5%)

 

rs3820841

 

TT

TC

CC

 
 

CDR 1

35 (25.4%)

62 (44.9%)

41 (29.7%)

**0.001

 

CDR 0.5

37 (22.8%)

49 (30.2%)

76 (46.9%)

 
 

CDR 0

42 (17.7%)

71 (30.0%)

124 (52.3%)

 

rs17746510

 

TT

TG

GG

 
 

CDR 1

48 (34.8%)

72 (52.2%)

18 (13.0%)

0.167

 

CDR 0

93 (39.2%)

101 (42.6%)

43 (18.1%)

 
 

CDR 1

48 (34.8%)

72 (52.2%)

18 (13.0%)

*0.036

 

CDR 0.5

62 (38.5%)

63 (39.1%)

36 (22.4%)

 
 

Combined

    
 

CDR 1

48 (34.8%)

72 (52.2%)

18 (13.0%)

0.13

 

CDR 0.5

62 (38.5%)

63 (39.1%)

36 (22.4%)

 
 

CDR 0

93 (39.2%)

101 (42.6%)

43 (18.1%)

 
  1. Abbreviations: CDR, Clinical Dementia Rating; SNP, single-nucleotide polymorphism. *P<0.05, **P<0.01 by χ2-tests.